Repligen Statistics
NASDAQ: RGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
159.87-7.35 (-4.40%)
Market open · Delayed 15 min · as of Oct 8, 11:33 AM ET
Repligen by the numbers
Repligen has a market capitalization of $10.15 billion based on 63.49M shares outstanding. Its trailing P/E ratio is 219.0, above the 4-company peer median of 36.0, and its forward P/E is 60.3. The stock trades 7.1% below its 50-day average and 11.2% above its 200-day average.
Average daily trading volume is 1.17M shares, or about $186.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RGEN valuation vs. peer median
| Metric | RGEN | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.15B | $9.77B | +4% |
| P/E (TTM) | 219.0 | 36.0 | +508% |
| Forward P/E | 60.3 | 24.2 | +150% |
| Avg. volume | 1.17M | 2.08M | -44% |
Peer median across 8 companies: IBRX, TWST, TECH, PCVX, KRYS, QGEN, HALO, KYMR.
Valuation
- Market cap
- $10.15B
- P/E (TTM)
- 219.00
- Forward P/E
- 60.34
- Price / sales (latest FY)
- 13.75
- EPS (TTM)
- $0.73
- Shares outstanding
- 63.49M
Price and trading
- Previous close
- 167.22
- Open
- 163.83
- Day range
- 157.44 – 164.65
- 52-week range
- 100.99 – 198.87
- 52-week change
- +14.59%
- 50-day moving average
- 172.13
- 200-day moving average
- 143.80
- Beta
- —
- Volume
- 373.90K
- Average volume
- 1.17M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 10.15B
- Pe
- 219.00
- Forward Pe
- 60.34
- Eps
- 0.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 198.87
- Week52 Low
- 100.99
- Avg Volume
- 1.17M
- Shares Outstanding
- 63.49M
- Ma50
- 172.13
- Ma200
- 143.80
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -19.61%
- Pct From52w Low
- 58.30%